News
The 61-year-old man received a new kidney from a deceased donor after being diagnosed with “nephrosclerosis-related end-stage ...
2d
Zacks.com on MSNBiogen Begins Phase III Felzartamab Study for Third Kidney DiseaseBIIB begins phase III dosing of felzartamab primary membranous nephropathy study, targeting a tough-to-treat condition with ...
But in the immunosuppressed, it can cause a deadly hyperinfection syndrome, with the worms going through accelerating and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results